Document is current
Any future updates will be listed below
-
Authors
Crispin-Ortuzar, Mireia https://orcid.org/0000-0002-4351-3709
Woitek, Ramona https://orcid.org/0000-0002-9146-9159
Reinius, Marika A. V. https://orcid.org/0000-0002-9778-3317
Moore, Elizabeth
Beer, Lucian https://orcid.org/0000-0003-4388-7580
Bura, Vlad
Rundo, Leonardo
McCague, Cathal https://orcid.org/0000-0002-9588-267X
Ursprung, Stephan https://orcid.org/0000-0003-2476-178X
Escudero Sanchez, Lorena https://orcid.org/0000-0003-3464-9206
Martin-Gonzalez, Paula
Mouliere, Florent https://orcid.org/0000-0001-7043-0514
Chandrananda, Dineika https://orcid.org/0000-0002-8834-9500
Morris, James
Goranova, Teodora
Piskorz, Anna M.
Singh, Naveena
Sahdev, Anju https://orcid.org/0000-0001-8520-3031
Pintican, Roxana
Zerunian, Marta
Rosenfeld, Nitzan https://orcid.org/0000-0002-2825-4788
Addley, Helen
Jimenez-Linan, Mercedes
Markowetz, Florian https://orcid.org/0000-0002-2784-5308
Sala, Evis
Brenton, James D. https://orcid.org/0000-0002-5738-6683
- License Information
-
More Information
Article History
Received: 27 May 2022
Accepted: 20 September 2023
First Online: 24 October 2023
Competing interests
: F.Mo., D.C., A.P., J.D.B. and N.R. are inventors of the patent “Enhanced detection of target DNA by fragment size analysis” (WO/2020/094775). N.R. and J.D.B. are inventors of the patent “TAm-Seq v2 method for ctDNA estimation” (WO 2016/009224A1). T.G. is an employee of and owns shares from AstraZeneca. F.Ma. and J.D.B. are founders and directors of Tailor Bio Ltd and own shares in Tailor Bio Ltd. J.D.B. has received honoraria and personal payments from AstraZeneca, GSK and Clovis Oncology. M.C.O. has received honoraria from GSK. E.S. is co-founder and shareholder of Lucida Medical Ltd. L.R. has received consulting fees from Lucida Medical Ltd. The remaining authors declare no competing interests.
